when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Cardiology · news · pharmadog

← back to Cardiology

News · Cardiology

332 stories

29dLilly, with new data, to seek FDA approval of obesity drug retatrutidebiopharma dive

29dFDA panel confronting peptide controversystat

29dSTAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and morestat

29dLilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 databiospace

29dSTAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefitstat

29dLilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clearfiercebiotech

Jul 22, 26FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilotfda press

Jul 22, 26Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drugbiospace

Jul 22, 26STAT+: Pharma tries to tamp down broad China restrictionsstat

Jul 22, 26Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely onbiospace

Jul 22, 26Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease studybiopharma dive

Jul 22, 26Crystalys nets $130M more to push gout drug through late-stage testsbiopharma dive

Jul 22, 26Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drugfiercebiotech

Jul 22, 26Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changerstat

Jul 22, 26Wainua flop narrows AstraZeneca’s path to $80B goal ahead of high-risk readoutsbiospace

Jul 21, 26Novartis climbs on upbeat drug sales as key readouts loombiopharma dive

Jul 21, 26Crystalys mines $130M series B to push gout drug through phase 3fiercebiotech

Jul 21, 26Novartis stays 'geography-agnostic' in dealmaking amid flurry of China dealsbiospace

Jul 20, 26Pain drugmaker Latigo outlines plans to go publicbiopharma dive

Jul 20, 26HHS vaccine committee quietly gets new charterstat

Jul 20, 26Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic medsfiercebiotech

Jul 20, 26Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industrystat

Jul 18, 26Opinion: Beware the unintended consequences of testosterone screening for military servicemembersstat

Jul 18, 26Opinion: STAT readers on the value of primary care, obesity as a disease, and morestat

Jul 17, 26Opinion: What the 20th-century war on smog tells us about today’s wildfire smokestat

Jul 17, 26FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterolfda press

Jul 17, 26GSK culls cough program for drug at the heart of $2B Bellus bet after Phase 3 failbiospace

Jul 17, 26Insmed moves closer to $6B opportunity as PAH drug shows long-term durabilitybiospace

Jul 17, 26Abbott Q2 led by strong device, diagnostic sales as it boosts profit forecastfiercebiotech

Jul 17, 26Biotronik Neuro snaps up spinal cord stimulation portfolio from Soin Neuroscience for next-gen pain projectfiercebiotech

← prevpage 5 of 12next →